InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Adaptive Biotechnologies Corp

ADPT Clue Score44
United States Fiscal year ends December CIK 0001478320
$25.57 -3.47% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $25.57 −21.83% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 27 Jun 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue38.4Operating income−44.5Net income−42.8Fiscal year 2018Revenue55.7 +44.8%Operating income−49.8Net income−46.4Fiscal year 2019Revenue85.1 +52.8%Operating income−78.4Net income−68.6Fiscal year 2020Revenue98.4 +15.6%Operating income−152.8Net income−146.2EPS, diluted−1.11Fiscal year 2021Revenue154.3 +56.9%Operating income−209.0Net income−207.3EPS, diluted−1.48Fiscal year 2022Revenue185.3 +20.1%Operating income−200.2Net income−200.2EPS, diluted−1.40Fiscal year 2023Revenue170.3 −8.1%Operating income−227.0Net income−225.3EPS, diluted−1.56Fiscal year 2024Revenue179.0 +5.1%Operating income−162.5Net income−159.5EPS, diluted−1.08Fiscal year 2025Revenue277.0 +54.8%Operating income−57.1Net income−59.5EPS, diluted−0.39
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 38.4 55.7 85.1 98.4 154.3 185.3 170.3 179.0 277.0
Growth +44.8% +52.8% +15.6% +56.9% +20.1% −8.1% +5.1% +54.8%
Operating income −44.5 −49.8 −78.4 −152.8 −209.0 −200.2 −227.0 −162.5 −57.1
Net income −42.8 −46.4 −68.6 −146.2 −207.3 −200.2 −225.3 −159.5 −59.5
Growth
EPS, diluted n/a n/a n/a −1.11 −1.48 −1.40 −1.56 −1.08 −0.39
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−115.7%Net margin−111.4%Free cash flow margin−97.0%Fiscal year 2018Operating margin−89.4%Net margin−83.4%Free cash flow margin−69.3%Fiscal year 2019Operating margin−92.1%Net margin−80.6%Free cash flow margin228.3%Fiscal year 2020Operating margin−155.3%Net margin−148.6%Free cash flow margin−171.3%Fiscal year 2021Operating margin−135.4%Net margin−134.3%Free cash flow margin−164.9%Fiscal year 2022Operating margin−108.0%Net margin−108.0%Free cash flow margin−108.1%Fiscal year 2023Operating margin−133.3%Net margin−132.3%Free cash flow margin−98.1%Fiscal year 2024Operating margin−90.8%Net margin−89.1%Free cash flow margin−55.3%Fiscal year 2025Operating margin−20.6%Net margin−21.5%Free cash flow margin−17.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −115.7% −89.4% −92.1% −155.3% −135.4% −108.0% −133.3% −90.8% −20.6%
Net margin −111.4% −83.4% −80.6% −148.6% −134.3% −108.0% −132.3% −89.1% −21.5%
Free cash flow margin −97.0% −69.3% 228.3% −171.3% −164.9% −108.1% −98.1% −55.3% −17.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−34.9Capital expenditure−2.4Free cash flow−37.3Fiscal year 2018Operating cash flow−32.3Capital expenditure−6.3Free cash flow−38.6Fiscal year 2019Operating cash flow205.4Capital expenditure−11.2Free cash flow194.2Fiscal year 2020Operating cash flow−149.7Capital expenditure−18.8Free cash flow−168.5 −186.8%Fiscal year 2021Operating cash flow−192.7Capital expenditure−61.7Free cash flow−254.5Fiscal year 2022Operating cash flow−183.9Capital expenditure−16.3Free cash flow−200.3Fiscal year 2023Operating cash flow−156.3Capital expenditure−10.7Free cash flow−167.0Fiscal year 2024Operating cash flow−95.2Capital expenditure−3.7Free cash flow−98.9Fiscal year 2025Operating cash flow−46.0Capital expenditure−3.0Free cash flow−48.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −34.9 −32.3 205.4 −149.7 −192.7 −183.9 −156.3 −95.2 −46.0
Capital expenditure −2.4 −6.3 −11.2 −18.8 −61.7 −16.3 −10.7 −3.7 −3.0
Free cash flow −37.3 −38.6 194.2 −168.5 −254.5 −200.3 −167.0 −98.9 −48.9
Growth −186.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Shareholders’ equity−224.6Fiscal year 2018Cash55.0Shareholders’ equity−258.1Fiscal year 2019Cash96.6Shareholders’ equity571.0Fiscal year 2020Cash123.4Shareholders’ equity743.3Fiscal year 2021Cash139.1Shareholders’ equity604.0Fiscal year 2022Cash90.0Total debt125.4Net cash (debt)−35.3Shareholders’ equity464.2Debt to equity0.27Fiscal year 2023Cash65.1Total debt130.7Net cash (debt)−65.6Shareholders’ equity308.4Debt to equity0.42Fiscal year 2024Cash47.9Total debt133.3Net cash (debt)−85.4Shareholders’ equity202.7Debt to equity0.66Fiscal year 2025Cash70.5Total debt131.2Net cash (debt)−60.7Shareholders’ equity218.8Debt to equity0.60
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash n/a 55.0 96.6 123.4 139.1 90.0 65.1 47.9 70.5
Total debt n/a n/a n/a n/a n/a 125.4 130.7 133.3 131.2
Net cash (debt) n/a n/a n/a n/a n/a −35.3 −65.6 −85.4 −60.7
Shareholders’ equity −224.6 −258.1 571.0 743.3 604.0 464.2 308.4 202.7 218.8
Debt to equity n/a n/a n/a n/a n/a 0.27 0.42 0.66 0.60

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−34.9 −32.3 205.4 −149.7 −192.7 −183.9 −156.3 −95.2 −46.0
Growth −172.9%
Investment
−2.4 −6.3 −11.2 −18.8 −61.7 −16.3 −10.7 −3.7 −3.0
calc −37.3 −38.6 194.2 −168.5 −254.5 −200.3 −167.0 −98.9 −48.9
Growth −186.8%
calc n/a n/a n/a −1.28 −1.81 −1.41 −1.16 −0.67 −0.32
36.4 0.7 −481.7 −117.0 181.2 2.9 129.6 77.8 38.0
Financing
50.0 1.2 319.9 293.6 27.1 132.3 2.2 0.2 30.4

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.